Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12624001324505
Ethics application status
Approved
Date submitted
10/12/2024
Date registered
12/12/2024
Date last updated
12/12/2024
Date data sharing statement initially provided
12/12/2024
Type of registration
Retrospectively registered

Titles & IDs
Public title
test
Scientific title
test
Secondary ID [1] 313271 0
123
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
test 335612 0
Condition category
Condition code
Cancer 332178 332178 0 0
Bone

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
test
Intervention code [1] 329862 0
Prevention
Comparator / control treatment
test
Control group
Placebo

Outcomes
Primary outcome [1] 339770 0
test
Timepoint [1] 339770 0
test
Primary outcome [2] 339772 0
test222
Timepoint [2] 339772 0
Primary outcome [3] 339773 0
test222
Timepoint [3] 339773 0
test123
Secondary outcome [1] 441169 0
test
Timepoint [1] 441169 0
test

Eligibility
Key inclusion criteria
test
Minimum age
15 Years
Maximum age
60 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
test

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Phase 0
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW

Funding & Sponsors
Funding source category [1] 317723 0
Government body
Name [1] 317723 0
test gov body
Country [1] 317723 0
Australia
Primary sponsor type
Government body
Name
gov body test name
Address
Country
Australia
Secondary sponsor category [1] 320039 0
Government body
Name [1] 320039 0
test 2
Address [1] 320039 0
Country [1] 320039 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 316413 0
test
Ethics committee address [1] 316413 0
Ethics committee country [1] 316413 0
Australia
Date submitted for ethics approval [1] 316413 0
01/12/2024
Approval date [1] 316413 0
03/12/2024
Ethics approval number [1] 316413 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 137810 0
Mr Geoffrey Hall
Address 137810 0
test
Country 137810 0
Australia
Phone 137810 0
+61 411123456
Fax 137810 0
Email 137810 0
Contact person for public queries
Name 137811 0
Geoffrey Hall
Address 137811 0
test
Country 137811 0
Australia
Phone 137811 0
+61 411123456
Fax 137811 0
Email 137811 0
Contact person for scientific queries
Name 137812 0
Geoffrey Hall
Address 137812 0
test
Country 137812 0
Australia
Phone 137812 0
+61 411123456
Fax 137812 0
Email 137812 0

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.